InvestorsHub Logo

Dr Bala

10/12/23 9:36 AM

#639774 RE: learningcurve2020 #639767

Thanks for another of those 'mic drop' posts. You don't seem to keep up with replies and go back to the same fud. Flipper already replied (link below) to the fudster-delusion's post.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173004810

The Danish Dude

10/12/23 9:57 AM

#639783 RE: learningcurve2020 #639767

Of course Paul Mulholland knows. We have known that as well for long.

Times article April 10th 2023.

https://www.thetimes.co.uk/article/brain-cancer-that-affects-3-200-patients-a-year-could-be-cured-with-trials-6dz5sf5l5

Paul Mulholland

“I'm actually very optimistic that we will cure it, and it could be very soon.”

Bullish
Bullish

beachhyena

10/12/23 10:00 AM

#639789 RE: learningcurve2020 #639767

It is astounding how little knowledge the bears have when it comes to treating the many kinds of brain cancers the world at large have to deal with. Your so called mic drop moment is a pathetic cry for attention from a nefarious group who's very actions have compromised the ability of NWBO to raise enough capital to do additional trials especially with DCVAX-D that could have helped this poor lady and 10,000's of others. Your greed is a stain on mankind and has no doubt caused innumerable pain that could have been prevented had NWBO been properly funded from the get-go. I am sure we would have seen many trials with DCVAX-D being performed that may have saved the lives of many desperate people who have had to suffer the use of current SOC that not only fleeces their life savings but also their end of life quality of life. We live in a sad world where man's greed for money overrides the beauty of life.

exwannabe

10/12/23 12:46 PM

#639877 RE: learningcurve2020 #639767

Wondering if anyone saw Mulholland's recent comment. Seems like he'd know.


Fairly clear. Dr Mulholland, a DCVax-L supporter, states the need to get trials going to get a new drug approved.

Paul Mulholland, a consultant in medical oncology at University College London hospitals NHS foundation trust, who treated Margaret privately, supports Siobhain’s campaign and says some drug firms are reluctant to provide drugs for trials because they say it is not financially viable to develop treatments for glioblastoma. He said: “The tumours that are less common get left behind. The treatment will be the same in 10 years’ time if we don’t do trials. We need to partner with the NHS and the pharmaceutical industry to get the trials for brain cancer patients.” He believes an effective treatment can be found within seven years with a comprehensive schedule of trials.[/quote

Reasonable timeline for somebody who does not expect a current P3 to yield approval.
.